Search Within

Lymphoma

Formats
  1. Meeting Abstract (1382)
  2. Journal Article (1056)
  3. Book Section (64)
  4. Review (64)
  5. Editorial (38)
  6. Research Letter (38)
  7. Guidelines (18)
  8. Conference Paper (15)
  9. Correspondence (11)
  10. Miscellaneous (5)
  11. Book Whole (4)
Groups
  1. Center for Hematologic Malignancies (2695)
  2. Department of Medicine (2695)
  3. Hematologic Malignancies, Division of (2695)
  4. Population Sciences Research Program (742)
  5. Survivorship Research (655)
  6. Executive Committee, Center for Hematologic Malignancies (391)

More Groups

People
  1. Andrew Zelenetz (781)
  2. Steven Horwitz (664)
  3. Maria Palomba (444)
  4. Ariela Noy (369)
  5. David Straus (360)
  6. Alison Moskowitz (355)

More People

Years
  1. 2025 (42)
  2. 2024 (141)
  3. 2023 (180)
  4. 2022 (170)
  5. 2021 (171)
  6. 2020 (170)

More Years

Publications
  1. Blood (876)
  2. Journal of Clinical Oncology (277)
  3. Hematological Oncology (110)
  4. British Journal of Haematology (81)
  5. Leukemia and Lymphoma (81)
  6. Haematologica (71)

More Publications

Publishers
  1. American Society of Hematology (941)
  2. American Society of Clinical Oncology (293)
  3. Elsevier Inc. (187)
  4. Wiley Blackwell (174)
  5. John Wiley & Sons (96)
  6. Nature Publishing Group (93)

More Publishers

Results (2695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Eomesodermin regulates the early activation of alloreactive CD4 T cells and is critical for both Gvh and GVL responses
    Meeting Abstract

    Du Rocher, B.; Smith, O. M.; Intlekofer, A. M.; Dudakov, J. A.; Levy, E.; Kreiners, F.; Reiner, S.; Abdelhay, E.; van den Brink, M. R. M.; Hanash, A. M.
    Blood (2013)

    Fulltext@MSK | Save
  • Treatment with the potent PI3K-,δ,γ inhibitor IPI-145 is associated with rapid decreases in specific cytokines, chemokines and matrix metalloproteinases in the serum of patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma
    Meeting Abstract

    Douglas, M.; Allison, K.; Ted, S.; Allen, K.; Kahl, B. S.; Horwitz, S. M.; Flinn, I. W.; Kelly, P.; Stern, H. M.
    Blood (2013)

    Fulltext@MSK | Save
  • Clinical activity of idelalisib (GS-1101), a selective inhibitor of PI3Kδ, in phase 1 and 2 trials in chronic lymphocytic leukemia (CLL): Effect of del(17p)/TP53 mutation, del(11q), IGHV mutation, and NOTCH1 mutation
    Meeting Abstract

    Coutre, S. E.; Leonard, J. P.; Barrientos, J. C.; De Vos, S.; Flinn, I.; Furman, R. R.; Brown, J. R.; Wagner-Johnston, N.; Benson, D. M. Jr; Schreeder, M. T.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Early relapse of follicular lymphoma after R-CHOP uniquely defines patients at high risk for death: An analysis from the National LymphoCare Study
    Meeting Abstract

    Casulo, C.; Byrtek, M.; Dawson, K. L.; Zhou, X.; Farber, C.; Flowers, C. R.; Hainsworth, J. D.; Link, B. K.; Zelenetz, A. D.; Friedberg, J. W.
    Blood (2013)

    Fulltext@MSK | Save
  • A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Preliminary results from the t-cell consortium trial
    Meeting Abstract

    Advani, R. H.; Ansell, S. M.; Lechowicz, M. J.; Beaven, A. W.; Loberiza, F. R. Jr; Carson, K. R.; Evens, A. M.; Foss, F. M.; Horwitz, S. M.; Pro, B.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Impact of renal insufficiency and obesity on safety and outcomes of BEAM conditioning
    Meeting Abstract

    Afifi, S.; Adel, N. G.; Zhang, Z.; Shi, W.; Moskowitz, C. H.; Matasar, M. J.
    Blood (2013)

    Fulltext@MSK | Save
  • The role of hematopoietic stem cell transplantation in peripheral T-cell lymphomas
    Book Section

    Goldberg, J. D.; Casulo, C.; Horwitz, S. M.
    In Quesenberry, P. J.; Castillo, J. J. (Eds.) Non-Hodgkin Lymphoma: Prognostic Factors and Targets (2013)

    Fulltext@MSK | Save
  • Antibody-drug conjugates in hematologic malignancies
    Journal Article

    Leslie, L. A.; Younes, A.
    American Society of Clinical Oncology Educational Book (2013)

    Fulltext@MSK | Save
  • Lymphoma and leukemia
    Book Section

    Stein, E.; Noy, A.
    In Mulhall, J. P.; Applegarth, L. D.; Oates, R. D.; Schlegel, P. N. (Eds.) Fertility Preservation in Male Cancer Patients (2013)

    Fulltext@MSK | Save
  • A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Furman, R. R.; Sharman, J. P.; Coutre, S. E.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I.; more...
    Blood (2013)

    Fulltext@MSK | Save